I2-imidazoline receptors in platelets of patients with Parkinson's disease and Alzheimer's type dementia.
Ulibarri
I
I
Department of Pharmacology, University of the Basque Country, Bizkaia, Spain.
Soto
J
J
Ruiz
J
J
Ballesteros
J
J
Jaúregui
J V
JV
Meana
J J
JJ
D000544:Alzheimer Disease / Q000097:blood*; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001792:Blood Platelets / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D006801:Humans; D019329:Idazoxan / Q000097:blood; D007093:Imidazoles / Q000378:metabolism; D054755:Imidazoline Receptors; D007700:Kinetics; D010300:Parkinson Disease / Q000097:blood* / Q000188:drug therapy; D011955:Receptors, Drug / Q000097:blood*; D012016:Reference Values; D012642:Selegiline / Q000627:therapeutic use
D000978:Antiparkinson Agents; D007093:Imidazoles; D054755:Imidazoline Receptors; D011955:Receptors, Drug; D012642:Selegiline; D019329:Idazoxan